OrPro Therapeutics

Call
Website
3210 Merryfield Row
San Diego, CA 92121
+1 (858) 242-1557
https://www.orprotherapeutics.com

OrPro Therapeutics Inc. is focused on developing the Theradux non-systemic biologic drug platform, aimed at addressing diseases of the lung and other epithelial surfaces marked by chronic infection, inflammation, and obstructive mucus. Their innovative approach includes the development of ORP100S, a novel biologic therapy designed to treat lung inflammation and obstruction related to chronic airway disorders and severe COVID-19 disease.

The company also specializes in addressing the unique challenges faced by patients with cystic fibrosis, where a genetic abnormality results in the production of excessively stiff and viscous mucus that complicates breathing and contributes to impaired lung function. Through their targeted research and development efforts, OrPro Therapeutics seeks to improve outcomes for individuals suffering from these debilitating conditions.

Generated from the website

Also at this address

Owner verified
See a problem?

You might also like

Cybele Microbiome Inc

Cybele Microbiome Inc, based in San Diego, CA, is a pioneering company dedicated to enhancing skin health through a profound understanding of the microbiome. By recognizing the microbiome as a vital component in inflammation control, infection protection, and wound healing, Cybele aims to revolutionize skincare by transforming traditional approaches that have long viewed it as an adversary. The company focuses on the intricate relationship between skincare ingredients and microbiome health, conducting clinical trials to demonstrate the efficacy of their innovative formulations. With a commitment to achieving better results and fewer side effects, Cybele collaborates with top scientists to unlock the potential of postbiotics for real skin improvement. Generated from the website

Xosomix LLC

Xosomix LLC is a biotechnology company based in San Diego, CA, focused on developing next-generation therapeutics utilizing exosomes. With a unique approach to treating brain disorders, Xosomix aims to enhance the efficacy of current medications and support cellular repair through the innovative use of exosomal technology. Founded on groundbreaking preclinical research demonstrating the therapeutic potential of exosomes in conditions such as Rett Syndrome, Xosomix is positioned within the biotech incubator JLABS by Johnson & Johnson Innovation. The company is dedicated to addressing the significant unmet needs in the $100 billion brain disorder therapeutics market. Generated from the website

National Resilience

National Resilience, a leading Contract Development and Manufacturing Organization (CDMO), specializes in biomanufacturing solutions aimed at accelerating the development of complex therapeutics. With a collaborative culture and a focus on innovative partnerships, the company supports a wide range of therapies, from drug substances to advanced cell and gene therapies. With facilities across North America, Resilience offers state-of-the-art capabilities in drug product manufacturing, packaging, and testing, ensuring quality and scalability in its operations. The company is committed to advancing public-private partnerships and enhancing access to medicines through its agile and audacious approach to biomanufacturing. Generated from the website
United States›California›San Diego›OrPro Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.